Changeflow GovPing Pharma & Drug Safety Brain Stimulation for Mild Cognitive Impairment
Routine Notice Added Final

Brain Stimulation for Mild Cognitive Impairment

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected April 6th, 2026
Email

Summary

The National Library of Medicine registered a new clinical trial (NCT07512193) on ClinicalTrials.gov. The study, sponsored by Johns Hopkins University, will evaluate brain stimulation as an intervention for mild cognitive impairment.

What changed

Johns Hopkins University registered a Phase 2 clinical trial (NCT07512193) on ClinicalTrials.gov investigating non-invasive brain stimulation for mild cognitive impairment. The study includes standard registration elements such as inclusion/exclusion criteria, enrollment targets, and outcome measures.

Clinical investigators and sponsors should verify their ongoing trials are properly registered and updated per FDAAA 801 requirements. Patients and caregivers can use this registry to identify recruiting studies. The NCT identifier can be used to reference the study in regulatory submissions and publications.

Source document (simplified)

Show glossary

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
NLM
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07512193

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical Trial Registration
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Clinical Research Public Health

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.